Herukka SK - Search Results

1

Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients.

Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttilä T. Ojala J, et al. Among authors: herukka sk. Neurobiol Aging. 2009 Feb;30(2):198-209. doi: 10.1016/j.neurobiolaging.2007.06.006. Epub 2007 Jul 20. Neurobiol Aging. 2009. PMID: 17658666

2

Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase.

Benussi A, Cantoni V, Grassi M, Libri I, Cotelli MS, Tarantino B, Datta A, Thomas C, Huber N, Kärkkäinen S, Herukka SK, Haapasalo A, Filosto M, Padovani A, Borroni B. Benussi A, et al. Among authors: herukka sk. Brain Stimul. 2023 Nov-Dec;16(6):1666-1676. doi: 10.1016/j.brs.2023.11.008. Epub 2023 Nov 15. Brain Stimul. 2023. PMID: 37977335 Free article. Clinical Trial.

3

Abeta levels in serum, CSF and brain, and cognitive deficits in APP + PS1 transgenic mice.

Liu L, Tapiola T, Herukka SK, Heikkilä M, Tanila H. Liu L, et al. Among authors: herukka sk. Neuroreport. 2003 Jan 20;14(1):163-6. doi: 10.1097/00001756-200301200-00030. Neuroreport. 2003. PMID: 12544850

4

Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic mice.

Liu L, Herukka SK, Minkeviciene R, van Groen T, Tanila H. Liu L, et al. Among authors: herukka sk. Neurobiol Dis. 2004 Dec;17(3):516-23. doi: 10.1016/j.nbd.2004.08.005. Neurobiol Dis. 2004. PMID: 15571987

5

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.

Herukka SK, Hallikainen M, Soininen H, Pirttilä T. Herukka SK, et al. Neurology. 2005 Apr 12;64(7):1294-7. doi: 10.1212/01.WNL.0000156914.16988.56. Neurology. 2005. PMID: 15824371

6

CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.

Herukka SK, Helisalmi S, Hallikainen M, Tervo S, Soininen H, Pirttilä T. Herukka SK, et al. Neurobiol Aging. 2007 Apr;28(4):507-14. doi: 10.1016/j.neurobiolaging.2006.02.001. Epub 2006 Mar 20. Neurobiol Aging. 2007. PMID: 16546302

7

CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy.

Herukka SK, Pennanen C, Soininen H, Pirttilä T. Herukka SK, et al. J Alzheimers Dis. 2008 May;14(1):51-7. doi: 10.3233/jad-2008-14105. J Alzheimers Dis. 2008. PMID: 18525127

8

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T. Tapiola T, et al. Among authors: herukka sk. Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596. Arch Neurol. 2009. PMID: 19273758

9

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K. Mattsson N, et al. Among authors: herukka sk. JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064. JAMA. 2009. PMID: 19622817

10

Longitudinal changes of CSF biomarkers in Alzheimer's disease.

Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK. Seppälä TT, et al. Among authors: herukka sk. J Alzheimers Dis. 2011;25(4):583-94. doi: 10.3233/JAD-2011-101911. J Alzheimers Dis. 2011. PMID: 21460434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page